相关实验视频

Updated: Jan 13, 2026

Single Droplet Digital Polymerase Chain Reaction for Comprehensive and Simultaneous Detection of Mutations in Hotspot Regions

Single Droplet Digital Polymerase Chain Reaction for Comprehensive and Simultaneous Detection of Mutations in Hotspot Regions

Published on: September 25, 2018

在KRAS突变检测和临床影响方面的进展和挑战

Maryam Sadat Mirlohi^1,2, Tooba Yousefi¹, Javad Razaviyan¹

¹Department of Clinical Biochemistry, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran 1985717413, Iran.

|January 10, 2026

概括

通过激活信号通路,KRAS突变驱动癌症. 新的检测方法对于开发向治疗和改善患者治疗结果至关重要.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
遗传学是一个遗传学.

背景情况:

异常的RAS信号通路激活是许多癌症的标志,通常是由RAS基因突变驱动的.
在RAS基因中的特定编码突变显著影响癌症患者的结果.
历史上,克拉斯被认为是无法治疗的,但新型抑制剂正在出现.

研究的目的:

提供KRAS突变检测方法的全面概述.
批判性地评估现有方法的准确性,敏感性,成本和临床适用性.
引导研究人员和临床医生选择合适的诊断工具.

主要方法:

综述各种KRAS突变检测技术,从仅用于研究到体外诊断.
基于关键绩效指标的公布结果的批判性评估.
对不同样本类型和临床环境的适用性分析.

主要成果:

已经开发了许多用于KRAS突变检测的方法,其目标是稳定性,速度,灵敏性,准确性和成本效益.
这些方法从基础研究工具到经过认证的临床诊断试验.
关于方法性能的公布数据各不相同,需要仔细评估.

结论:

准确的KRAS突变鉴定对于个性化癌症治疗策略至关重要.
有效的KRAS抑制剂的开发强调了可靠的检测方法的重要性.
本综述是了解KRAS突变检测技术的资源.

关键词:

在KRAS突变中发生突变.分子方法分子方法.在基因上,我们发现了基因上的差异.精准医学是一门精准医学.有针对性的治疗.

更多相关视频

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

Published on: December 7, 2014

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

相关概念视频

The Ras Gene

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...

Small GTPases - Ras and Rho

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity: